| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 6 | US FAERS | |
| 2 | Leukocytosis | FAERS: 4 | US FAERS | |
| 3 | Burning sensation | FAERS: 3 | US FAERS | |
| 4 | Hypersensitivity | FAERS: 3 | US FAERS | |
| 5 | Night sweats | FAERS: 3 | US FAERS | |
| 6 | Product quality issue | FAERS: 3 | US FAERS | |
| 7 | Pruritus | FAERS: 3 | US FAERS | |
| 8 | Abdominal Pain | FAERS: 2 | US FAERS | |
| 9 | Colitis | FAERS: 2 | US FAERS | |
| 10 | Dehydration | FAERS: 2 | US FAERS | |
| 11 | Device use issue | FAERS: 2 | US FAERS | |
| 12 | Headache | FAERS: 2 | US FAERS | |
| 13 | Ileitis | FAERS: 2 | US FAERS | |
| 14 | Lip swelling | FAERS: 2 | US FAERS | |
| 15 | Palmar erythema | FAERS: 2 | US FAERS | |
| 16 | Post procedural complication | FAERS: 2 | US FAERS | |
| 17 | Syncope | FAERS: 2 | US FAERS | |
| 18 | Tinnitus | FAERS: 2 | US FAERS | |
| 19 | Acne | FAERS: 1 | US FAERS | |
| 20 | Blindness | FAERS: 1 | US FAERS | |
| 21 | Candidiasis | FAERS: 1 | US FAERS | |
| 22 | Clostridium difficile colitis | FAERS: 1 | US FAERS | |
| 23 | Deafness Neurosensory | FAERS: 1 | US FAERS | |
| 24 | Deafness | FAERS: 1 | US FAERS | |
| 25 | Enteritis | FAERS: 1 | US FAERS | |
| 26 | Facial Pain | FAERS: 1 | US FAERS | |
| 27 | Gastrointestinal infection | FAERS: 1 | US FAERS | |
| 28 | Liquid product physical issue | FAERS: 1 | US FAERS | |
| 29 | Nausea | FAERS: 1 | US FAERS | |
| 30 | Onychoclasis | FAERS: 1 | US FAERS | |
| 31 | Photophobia | FAERS: 1 | US FAERS | |
| 32 | Proctitis | FAERS: 1 | US FAERS | |
| 33 | Psychiatric symptom | FAERS: 1 | US FAERS | |
| 34 | Tachycardia | FAERS: 1 | US FAERS | |
| 35 | Urticaria | FAERS: 1 | US FAERS | |
| 36 | Vomiting | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.